Is Hyundai Bioscience Co., stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Hyundai Bioscience Co., pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Monday 29th of December 2003 were paid KRW100 per share. Over the last 2 times between 2002 and 2003, Hyundai Bioscience Co., has paid KRW200 with an average of KRW100 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Hyundai Bioscience Co., 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was KRW12 300, you would have made a profit of KRW7 480.00 per share or 60.81%
Yes, the average daily trading liquidity for Hyundai Bioscience Co., is KRW405 097 thousand. You should therefore be able to get in and out of your positions relatively fast.
Hyundai Bioscience Co., has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Hyundai Bioscience Co., to be high [0.85 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.